Airware Labs (OTCMKTS:AIRW) and Inogen (NASDAQ:INGN) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.
Insider and Institutional Ownership
98.6% of Inogen shares are held by institutional investors. 5.3% of Inogen shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
This table compares Airware Labs and Inogen’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a breakdown of current ratings and price targets for Airware Labs and Inogen, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Inogen has a consensus price target of $195.80, suggesting a potential upside of 105.85%.
Valuation & Earnings
This table compares Airware Labs and Inogen’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Inogen||$358.11 million||5.79||$51.85 million||$2.30||41.36|
Inogen has higher revenue and earnings than Airware Labs.
Inogen beats Airware Labs on 8 of the 8 factors compared between the two stocks.
Airware Labs Company Profile
Airware Labs Corp. develops, manufactures, and distributes nasal breathing devices. The company's products include Air Allergy, a discreet personal filter, which protects from irritating airborne allergens; and Air Sleep/Snore, a drug-free relief for congestion and snoring caused by nasal breathing difficulties. It focuses on offering its products to sleeping partners, individuals with chronic sinus issues, individuals that suffer from chronic sleep disorders, and individuals with allergies in the United States, Canada, Asia, and the European Union. The company was founded in 2010 and is headquartered in Scottsdale, Arizona.
Inogen Company Profile
Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.
Receive News & Ratings for Airware Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Airware Labs and related companies with MarketBeat.com's FREE daily email newsletter.